** Shares of contract drug development company Integer
Holdings ITGR.N fall 2.9% to $139.02 in morning trade
** Company expects 2025 adj. profit to be between $5.84 and
$6.20 per share, with the midpoint below analysts' estimates of
$6.07, according to data compiled by LSEG
** ITGR posts Q4 profit of $1.43 per share, slightly below
analysts' estimates of $1.46 per share
** Company says markets sales decreased 17% in Q4 2024
compared to a year ago, after the exit from its portable medical
unit, which was announced in 2022
** Company expects to close the acquisition of waterproof
electronic coating maker VSi Parylene for about $28 million by
the end of this month
** ITGR has risen ~39% in the last 12 months
(Reporting by Siddhi Mahatole)
((Siddhiprabhanjan.mahatole@thomsonreuters.com))